Literature DB >> 3004571

Nucleotide sequence of cloned cDNA for human pancreatic kallikrein.

D Fukushima, N Kitamura, S Nakanishi.   

Abstract

Cloned cDNA sequences for human pancreatic kallikrein have been isolated and determined by molecular cloning and sequence analysis. The identity between human pancreatic and urinary kallikreins is indicated by the complete coincidence between the amino acid sequence deduced from the cloned cDNA sequence and that reported partially for urinary kallikrein. The active enzyme form of the human pancreatic kallikrein consists of 238 amino acids and is preceded by a signal peptide and a profragment of 24 amino acids. A sequence comparison of this with other mammalian kallikreins indicates that key amino acid residues required for both serine protease activity and kallikrein-like cleavage specificity are retained in the human sequence, and residues corresponding to some external loops of the kallikrein diverge from other kallikreins. Analyses by RNA blot hybridization, primer extension, and S1 nuclease mapping indicate that the pancreatic kallikrein mRNA is also expressed in the kidney and sublingual gland, suggesting the active synthesis of urinary kallikrein in these tissues. Furthermore, the tissue-specific regulation of the expression of the members of the human kallikrein gene family has been discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004571     DOI: 10.1021/bi00348a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice.

Authors:  W Xiong; J Wang; L Chao; J Chao
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  The influence of age, sex and race on salivary kallikrein levels in human mixed saliva.

Authors:  J W Jenzano; S L Hogan; R L Lundblad
Journal:  Agents Actions       Date:  1992-01

Review 3.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Molecular biology of tissue kallikrein.

Authors:  R J MacDonald; H S Margolius; E G Erdös
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

5.  A novel protease homolog differentially expressed in breast and ovarian cancer.

Authors:  A Anisowicz; G Sotiropoulou; G Stenman; S C Mok; R Sager
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

Review 6.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  Tissue kallikrein in human placenta in early and late gestation.

Authors:  G Valdés; C Chacón; J Corthorn; C D Figueroa; A M Germain
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

8.  Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity.

Authors:  D R Wines; J M Brady; E M Southard; R J MacDonald
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

9.  Activation by Phoneutria nigriventer (armed spider) venom of tissue kallikrein-kininogen-kinin system in rabbit skin in vivo.

Authors:  R A Marangoni; E Antunes; S D Brain; G de Nucci
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Blarina toxin, a mammalian lethal venom from the short-tailed shrew Blarina brevicauda: Isolation and characterization.

Authors:  Masaki Kita; Yasuo Nakamura; Yuushi Okumura; Satoshi D Ohdachi; Yuichi Oba; Michiyasu Yoshikuni; Hiroshi Kido; Daisuke Uemura
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.